Hmo

Improved strain-specific use of HMOs identified in DuPont-backed study

20-Oct-2020 By Will Chu

Probiotic strain specificity is crucial if the benefits of human milk oligosaccharides (HMOs) such as 2′-fucosyllactose are to be passed on to the infant, according to a DuPont-sponsored study.

Gut simulation expands health benefits of HMOs in adults

28-Sep-2020 By Stephen Daniells

The potential health effects of human milk oligosaccharides (HMOs) for adults may extend beyond just promoting the growth of beneficial Bifidobacteria to also impacting immune function and the gut barrier, says a new study.

Chr. Hansen adds Jennewein HMO expertise to microbial platform in €310m deal

24-Sep-2020 By Will Chu

Chr. Hansen is to acquire Jennewein Biotechnologie for €310m in a deal designed to merge the bioscience firm’s probiotic interests with the gains Jennewein have made in the Human Milk Oligosaccharides (HMO) market.

Probiotics help preterm babies establish a 'normal' microbiome: Study

27-Aug-2020 By Danielle Masterson

Specific strains of probiotic Bifidobacterium and Lactobacillus bacteria given to preterm babies in combination with breast milk may help to build microbial populations and gut health that mirror those of full-term babies, suggests data from the Baby-Associated...

HMOs for NEC: Abbott-Johns Hopkins researchers unlock breastmilk prebiotics intestinal mechanism

09-Apr-2020 By Stephen Daniells

Human milk oligosaccharides (HMOs) may prevent the development of necrotizing enterocolitis (NEC) in premature infants by inhibiting a specific receptor in the intestine linked to inflammation, researchers from Johns Hopkins and Abbott report for the...

3-FL demonstrates safe use for food and dietary supplements: Study

25-Feb-2020 By Danielle Masterson

DuPont Nutrition & Biosciences continues its foray into digestive health by ramping up research on human milk oligosaccharides (HMOs).

DSM acquires HMO firm Glycom in €765m deal

25-Feb-2020 By Will Chu

Royal DSM has reached agreement to acquire Danish Human Milk Oligosaccharide (HMO) supplier Glycom in a deal worth €765m.

NIU’s Global Round-Up: More infant milk formulators are focusing their efforts on gut and brain health, breast milk linked to baby growth, and more

24-Feb-2020 By Danielle Masterson

What’s happened across the Nutra-verse over the past seven days? Stay on top of things with our weekly round-up of key news from across the globe.

BASF joins the HMO club with 2’-FL launch

23-Oct-2019 By Stephen Daniells

Human milk oligosaccharides (HMOs) are the “hot new thing” said an expert recently, as BASF announced the US launch of its 2’-FL (2’-fucosyllactose) ingredient, which is branded Prebilac.

Vitafoods Asia 2018

HMOs a goldmine of human health applications beyond infant formula: DuPont expert

12-Sep-2018 By Cheryl Tay

Human milk oligosaccharides (HMOs) have extensive potential to offer a range of health benefits in products beyond infant formula, DuPont's global business director for HMOs, Steen Lyck, said at Vitafoods Asia on Tuesday.